A5042957752- COVID-19 Clinical Research Studies
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes and associated disorders
- Renal cell carcinoma treatment
- Long-Term Effects of COVID-19
- Pancreatitis Pathology and Treatment
- Clinical practice guidelines implementation
- Pharmaceutical studies and practices
- Renal and related cancers
- HER2/EGFR in Cancer Research
- Renal Diseases and Glomerulopathies
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Financial Literacy and Behavior
- Antiplatelet Therapy and Cardiovascular Diseases
- Synthesis and Biological Evaluation
- Hemoglobinopathies and Related Disorders
- Medical and Health Sciences Research
- COVID-19 Impact on Reproduction
- COVID-19 and healthcare impacts
- Economic and Financial Impacts of Cancer
- Therapeutic Uses of Natural Elements
- Gastrointestinal motility and disorders
- Angiogenesis and VEGF in Cancer
- Influenza Virus Research Studies
Pfizer (United States)
2025
Centre Hospitalier Régional et Universitaire de Nancy
2020-2021
Université de Lorraine
2020-2021
Pitié-Salpêtrière Hospital
2015-2017
Sorbonne Université
2015-2017
Birmingham Children's Hospital
2016
Klinikum rechts der Isar
2009
In collaboration with state, tribal, local, and territorial health departments, CDC established the U.S. Zika Pregnancy Registry (USZPR) in early 2016 to monitor pregnant women laboratory evidence of possible recent virus infection their infants.This report includes an analysis completed pregnancies (which include live births pregnancy losses, regardless gestational age) 50 states District Columbia (DC) reported USZPR from January 15 December 27, 2016. Birth defects potentially associated...
Abstract Aim To investigate the association between routine use of dipeptidyl peptidase‐4 (DPP‐4) inhibitors and severity coronavirus disease 2019 (COVID‐19) infection in patient with type 2 diabetes a large multicentric study. Materials Methods This study was secondary analysis CORONADO on 2449 patients (T2D) hospitalized for COVID‐19 68 French centres. The composite primary endpoint combined tracheal intubation mechanical ventilation death within 7 days admission. Stabilized weights were...
Objectives: To describe the Sertraline Pediatric Registry for Evaluation of Safety (SPRITES) safety results, including adverse events (AEs) (serious and nonserious, suicide-related events) following long-term treatment with sertraline in children adolescents aged 6-16 years. Methods: SPRITES was a multicenter, prospective, observational study designed to compare cognitive, emotional, physical development pediatric patients exposed or psychotherapy alone routine care up 3 outcomes included...
The COVID-19 pandemic led to an international health crisis and restrictions. While the phenotype associated with severity in people diabetes has rapidly been explored, impact of restrictive measures, including lockdown, tertiary care disruption on metabolic control access healthcare remained unknown. aim our study was provide a comprehensive assessment overall management during glucose control, weight changes, consumption use alternative forms such as telemedicine services, large sample...
There are limited data evaluating the activity of cabozantinib (CABO) as second line (2L) therapy post standard care ipilimumab-nivolumab (IPI-NIVO) or immuno-oncology(IO)/vascular endothelial growth factor inhibitor (VEGFi) combinations (IOVE).Using IMDC database, we sought to identify objective response rate, time treatment failure (TTF) and overall survival (OS) 2L CABO after IPI-NIVO, IOVE combinations, pazopanib sunitinib (PAZ/SUN) other first (1L) therapies. Multivariable Cox...
The recent results of Cardiovascular Outcomes Trials (CVOTs) in type 2 diabetes have clearly established the cardiovascular (CV) safety or even benefit two therapeutic classes, Glucagon-Like Peptide-1 receptor agonists (GLP-1 RA) and Sodium-Glucose Co-Transporter-2 inhibitors (SGLT-2i). Publication latest CVOTs for these classes also led to an update ESC guidelines ADA/EASD consensus report 2019, which considers using GLP-1 RA SGLT-2i with proven early management diabetic patient disease...
318 Background: There are limited data to understand the activity of cabozantinib (CABO) as second line (2L) therapy post standard care ipilimumab-nivolumab (IPI-NIVO) or immuno-oncology(IO)/vascular endothelial growth factor (VEGF) inhibitor combinations (IOVE). The subsequent 3L approved therapies CABO has not been established. Methods: Using IMDC dataset, we examined all patients who received 2L CABO. We sought identify overall response rate (ORR), time treatment failure (TTF) and...
Aims of the study included evaluation outpatient antibiotic prescribing practices relating to good Antimicrobial Stewardship1 focusing on documentation indication and duration.Prescriptions dispensed at Outpatient Pharmacy over a 6 week were evaluated. Data collected include patient's hospital identification in full, prescribed, duration treatment, (in specifically allocated area prescription) route administration, prescriber speciality grade. entered onto Microsoft Excel reviewed by...
Since the start of COVID-19 pandemic, patients with diabetes were rapidly recognized as a high-risk population for severe disease. Indeed, high prevalence among who required hospitalization has been consistently reported, reaching 33.8% in 5,700 people hospitalized New York City area (1). In addition, was associated more than double risk intensive care unit (ICU) admission and triple death (2). However, precise data regarding type are scarce. We report here clinical characteristics early...
180 Background: Anemia in cancer patients is common. The LIDOANEMIA-1 survey [Scotté F. MASCC 2015] reported that French clinicians do not follow EORTC guidelines. We aimed at improving guidelines dissemination among physicians (FP). This second assessing the impact of our initiative on physicians’ behavior. Methods: Declarative conducted France. intervention consisted having watch a short video summarizing and their main messages for clinical practice. Evaluation was performed with...
e20739 Background: Anemia in cancer patients is common and may present with multiple etiologies, including itself, chemotherapy, iron functional deficiency, erythropoietin deficiency due to underlying renal disease. Its treatments include supplementation (IS), erythropoiesis-stimulating agents (ESAs), red blood cell (RBC) transfusion. National/international recommendations are available, but not always followed the clinical practice setting. Methods: Declarative survey conducted France...
Einleitung: Pfortaderthrombose ist eine häufige Komplikation bei Leberzirrhose bzw. -fibrose unterschiedlicher Genese. Dies kann zur Ausbildung von Ösophagus- und Fundusvarizen, Splenomegalie mit Hypersplenismuns Aszites führen. Die Differenzialdiagnosen einer abdominellen Venenthrombose sind sehr umfangreich schwierig. Wir berichten 3 Patienten (zwei Frauen, ein Mann, Durchschnittsalter 63 Jahre) Pfortader- Mesenterialvenenthrombose unklarer Genese unauffälliger Leberfunktion -morphologie...
Hintergrund: Die adäquate Darmreinigung ist weiterhin die unabdingbare und ungeliebte Voraussetzung einer suffizienten Koloskopie. Hierzu finden verschiedene Präparationen Anwendung, darunter auch mit 4–6 Litern Macrogol 4000. Schwere Nebenwirkungen wie klinisch relevante Verschiebung von Serumelektrolyten werden kasuistisch beschrieben. Viel häufiger scheint das Problem der schlechten Bekömmlichkeit. Aktuelle systematische Daten hierzu sind selten. Daher war es Ziel unserer Studie...
Background The potential prognostic value of hypertension and proteinuria anti- vascular endothelial growth factor (VEGF) drugs has not been assessed in routine clinical practice so far metastatic renal cell carcinoma (mRCC). objectives were to (i) assess the prevalence at baseline; (ii) their incidence under anti-VEGF drug treatment; (iii) evaluate a possible link with overall survival. Methods Patients from 8 centers included between 2009 2011 follow-up 1 year. They naïve any previous...
Since the start of COVID-19 pandemic, patients with diabetes were rapidly recognized as a high-risk population for severe disease. Indeed, high prevalence among who required hospitalization has been consistently reported, reaching 33.8% in 5,700 people hospitalized New York City area (1). In addition, was associated more than double risk intensive care unit (ICU) admission and triple death (2). However, precise data regarding type are scarce. We report here clinical characteristics early...
The REWIND study demonstrated a cardiovascular (CV) benefit of dulaglutide treatment in patients with type 2 diabetes (T2D) or without established disease (CVD). current aims to describe similarities and differences between characteristics T2D France the population. A retrospective, observational was conducted using primary care IQVIA electronic medical records. Patients aged ≥ 18 years at least one clinical visit and/or glucose-lowering agent prescription 2019 were identified. percentages...